Risk Factors for Rebleeding after Emergency Endoscopic Treatment of Dieulafoy Lesion

Table 4

Rebleeding rate of each hemostatic technique based on the risk factors.

		Pure injection	Nonpure injection	Combination therapy
PT > 12 or WBC ≥10 × 10^9/L	Rebleeding	8(42.1%)	6(20.7%)	4(12.5%)	0.048
	Nonrebleeding	11(57.9%)	23(79.3%)	28(87.5%)
PT ≤ 12 and WBC <10 × 10^9/L	Rebleeding	6(50%)	0	2(8.7%)	0.001
	Nonrebleeding	6(50%)	18	21(91.3%)